APA
Gallagher C. M., More K., Masaquel A. S., Kamath T., Guerin A., Ionescu-Ittu R., Gauthier-Loiselle M., Nitulescu R., Sicignano N., Barnett B. & Wu E. Q. (20160610). Overall Survival in Patients with HER2+ Early Stage Breast Cancer Patients Treated with Trastuzumab in the US Department of Defense Practice Setting. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
Chicago
Gallagher C M, More K, Masaquel A S, Kamath T, Guerin A, Ionescu-Ittu R, Gauthier-Loiselle M, Nitulescu R, Sicignano N, Barnett B and Wu E Q. 20160610. Overall Survival in Patients with HER2+ Early Stage Breast Cancer Patients Treated with Trastuzumab in the US Department of Defense Practice Setting. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
Harvard
Gallagher C. M., More K., Masaquel A. S., Kamath T., Guerin A., Ionescu-Ittu R., Gauthier-Loiselle M., Nitulescu R., Sicignano N., Barnett B. and Wu E. Q. (20160610). Overall Survival in Patients with HER2+ Early Stage Breast Cancer Patients Treated with Trastuzumab in the US Department of Defense Practice Setting. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
MLA
Gallagher C M, More K, Masaquel A S, Kamath T, Guerin A, Ionescu-Ittu R, Gauthier-Loiselle M, Nitulescu R, Sicignano N, Barnett B and Wu E Q. Overall Survival in Patients with HER2+ Early Stage Breast Cancer Patients Treated with Trastuzumab in the US Department of Defense Practice Setting. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 20160610.